Date Hour Room Track
04th December,2018 14:30-16:00 Track 2

What are the latest common actions jointly taken by the industry, academic institutions, equity investors and governmental institutions to take the assets the earliest and inject the proper amount of money to drive the projects towards licensing at the right moment and safest stage as possible.

Steven J. Klein - IRICoR - Institute for Research in Immunology and Cancer-Commercialization of Research
Michael L. Salgaller - National Institutes of Health (NIH) | National Cancer Institute (NCI) | Technology Transfer Center

Continue your tour